Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2003
05/21/2003EP0735867B1 Transdermal delivery device containing an estrogen
05/21/2003EP0706394B1 Use of a compostion comprising histamine phosphate for the manufacture of a medicament for the topical treatment of epithelial inflammation or lesions
05/21/2003CN1419472A Lipid nanocapsules, preparation method and use and medicine
05/21/2003CN1419453A Pharmaceutical gel composition
05/21/2003CN1419451A Novel galneical form for oral administration with prolonged release of molsidomine
05/21/2003CN1419449A Sustained release oral preparations
05/21/2003CN1419446A Sustained-release preparation and process for producing the same
05/21/2003CN1419445A Agent and binding agent for pharmaceutical formulations with improved storage stability
05/21/2003CN1419444A Pharmaceutical composition of topiramate
05/21/2003CN1419443A Continuous method for preparing pharmaceutical granules
05/21/2003CN1419442A Method of administering a medicinal aerosol formulation
05/21/2003CN1419441A Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent
05/21/2003CN1419418A Method of producing oily suspensions of water-soluble vitamins
05/21/2003CN1418869A 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine
05/21/2003CN1418703A Nano particle feeding system for oral use
05/21/2003CN1418702A Guilingxianchao soft extract and preparation method thereof
05/21/2003CN1418684A Medicine composition for treating gynaecology inflammation and its prepn. method
05/21/2003CN1418656A Capsule for treating gynaecologic inflammation, and its prepn. process
05/21/2003CN1418655A Aerosol for treating burn and scald, and its prepn-process
05/21/2003CN1418654A Pain-relieving capsule, and its prepn. process
05/21/2003CN1418638A Ribavirin oral disintegrant for treating virus influenza, and its prepn. method
05/21/2003CN1418637A Silicibinin-N-methylglucamine disperser for treating hepatitis, and its prepn. method
05/21/2003CN1418635A Aspirin oral disintegrant used for treating influenza and fever, and its prepn. method
05/21/2003CN1418634A Prednisolone oral disintegrant for treating acute bacterial infection, and its prepn. method
05/21/2003CN1418631A Zopiclone oral disintegrant for treating insomnia, and its prepn. method
05/21/2003CN1418629A Tipepidine oral disintegrant for treating tussis and expectoration, and its prepn. method
05/21/2003CN1418628A Fentanyl oral disintegrant for treating pain, and its prepn. method
05/21/2003CN1418627A Nitrophendipine oral disintegrant for treating angina pectoris, and its prepn. method
05/21/2003CN1418626A Nimodipine lipid nano particle compositions, and its prepn. method
05/21/2003CN1418624A Alizapride oral disintegrant for treating emesis
05/21/2003CN1418620A Quick disintegrated tablet or oral cavity disintegrated tablet containing L-glutamic acid and azulene sodium sulfonate and making method thereof
05/21/2003CN1418619A Slow released parts of volatile medicine and air conditioner using same
05/21/2003CN1418618A Oral cavity disintegration type solid preparation and method for making same
05/21/2003CN1109103C Artificial culture of jiuzhou caterpillar fungus and the application of its sporophore
05/21/2003CN1109102C Needleless syringe using supersonis gas flow for particle delivery
05/21/2003CN1109046C Induction of cytotoxic T-lymphocyte responses
05/21/2003CN1108967C Metering valve
05/21/2003CN1108823C Excipient stabilization of polypeptides treated with organic solvents
05/21/2003CN1108822C Pharmaceutical composition containing lornoxicam and disodic salt of EDTA
05/21/2003CN1108818C Activated immune globulin
05/21/2003CN1108815C Compound alpha interferon lozenge and its preparing method
05/21/2003CN1108810C Medicine for treating psoriasis and preparing process thereof
05/21/2003CN1108809C Meidicine for treating leukoderma and preparing process thereof
05/21/2003CN1108804C Diabetes treating medicine and its prepn. method
05/21/2003CN1108798C Compound preparation for curing and preventing thrombosis and apoplexy and its preparing method
05/21/2003CN1108792C External-use medicine composition for treating angioma and preparation method thereof
05/21/2003CN1108791C Galenic formula with extended release of milnacipran
05/21/2003CN1108790C Pharmaceutical compostion for transdermic delivery
05/21/2003CN1108789C Liposomes contg. particulate materials
05/21/2003CN1108783C Wound medicine moisture maintaining dressing
05/20/2003US6567705 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
05/20/2003US6566409 Lock and key micelles
05/20/2003US6566406 Biocompatible crosslinked polymers
05/20/2003US6566398 Method for treatment of external secretion disorders
05/20/2003US6566396 Carbetapentane tannate and chlorpheniramine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, and unproductive cough
05/20/2003US6566368 Aministering apomorphine or a pharmaceutically acceptable acid addition salt thereof intranasally and in an amount sufficient to induce an erection adequate for vaginal penetration but less than the amount that induces substantial nausea
05/20/2003US6566354 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
05/20/2003US6566350 Minocycline-containing compositions
05/20/2003US6566347 For therapy of endometriosis, infertility, hereditary angioedema, autoimmune disease, premenopausal abnormal bleeding, migraine headaches, and metastatic and fibrocystic breast diseases
05/20/2003US6566345 Polyacid/polyalkylene oxide foams and gels and methods for their delivery
05/20/2003US6566338 Administering caspase inhibitor for therapy of oral mucositis, gastrointestinal mucositis, bladder mucositis or proctitis resulting from chemotherapy or radiation therapy of cancer in an animal
05/20/2003US6566324 Preventing airway mucus production by administration of EGF-R antagonists
05/20/2003US6566095 Blocking transmission of viral particles to animals; obtain animal, administer antibody, incubate with viral sample, monitor viral infection, reduction in viral infection indicates antagonist
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6565960 Polymer composite compositions
05/20/2003US6565897 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
05/20/2003US6565889 Bilayer membrane structure encapsulates multiple containment units; drug delivery
05/20/2003US6565888 Sustained release; microparticles; immunomoderators
05/20/2003US6565887 Magnetic heating efficiency, alternating frequency; antitumor, anticarcinogenic agents
05/20/2003US6565886 Lipid core, water insoluble envelopes
05/20/2003US6565885 Methods of spray drying pharmaceutical compositions
05/20/2003US6565883 Delay dissolving in water, gastric juice
05/20/2003US6565882 Four dosage forms with different release profiles providing for initial release of a beta lactam antibiotic followed by release of a beta-lactamase inhibitor
05/20/2003US6565880 Antiinflammatory agents
05/20/2003US6565879 Neutralization; adjustment drug flux
05/20/2003US6565877 Blend of methacrylic acid copolymer and polyester
05/20/2003US6565876 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
05/20/2003US6565875 Microcapsules for administration of neuroactive agents
05/20/2003US6565874 Polymeric delivery formulations of leuprolide with improved efficacy
05/20/2003US6565873 Nanoparticles containing hydrophobic core; heating, dispersing, mixing, cooling
05/20/2003US6565872 Polymeric system for drug delivery and solute separation
05/20/2003US6565871 For administration of a bioactive material to subcutaneous and intradermal tissue
05/20/2003US6565866 Iodophor compositions
05/20/2003US6565861 Lipid binding protein in aqueous electrolytes; therapy for dry eyes
05/20/2003US6565859 Galenical formulations
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565850 Hemorrhoidal compositions and method of use
05/20/2003US6565842 Crosslinking gel
05/20/2003US6565841 Pulmonary administration of granulocyte colony stimulating factor
05/20/2003US6565833 Medicinal aerosol formulation
05/20/2003US6565832 Spray composition with reduced dripping
05/20/2003US6565777 In a polymer microparticle in a (water-in-oil)-in-water emulsion-based method, and using a solvent that comprises ethyl acetate.
05/20/2003CA2215534C Stable protein: phospholipid compositions and methods
05/20/2003CA2140665C Use of water-soluble or water-dispersible polyurethanes as auxiliary agents in cosmetic and pharmaceutical preparations and polyurethanes containing polylactic acid polyols incorporated by polymerization
05/20/2003CA2088254C Treatment for hypercholesterolemia
05/20/2003CA2084194C Oral delivery systems for microparticles
05/19/2003CA2363528A1 Immediate release tablet containing naproxen sodium
05/16/2003CA2411889A1 Films containing starch
05/16/2003CA2363376A1 Solid pharmaceutical compositions for oral administration comprising itraconazole
05/15/2003WO2003040686A2 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
1 ... 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 ... 2991